J. Lehmann

发表

Quinolinic acid evokes [3H]acetylcholine release in striatal slices: mediation by NMDA-type excitatory amino acid receptors.

J. Coyle, J. Lehmann, P. Schaefer, 1983, European journal of pharmacology.

In vivo investigations on the cholinesterase-inhibiting effects of tricyclic quinazolinimines: Scopolamine-induced cognitive impairments in rats are attenuated at low dosage and reinforced at higher dosage

K. Mohr, C. Tränkle, J. Lehmann, 2008, Pflügers Archiv - European Journal of Physiology.

Determination of Acetylcholine Dynamics

P. Wood, D. Cheney, J. Lehmann, 1989 .

Monthlyupdate - Central & peripheral nervous systems: Pharmacotherapeutic potential for compounds acting at NMDA receptors: Update 1995

J. Lehmann, J. Vender, S. Nair, 1995 .

The use of kainic acid in the localization of enzymes in the substantia nigra

H. Fibiger, S. Vincent, E. Mcgeer, 1978, Brain Research.

Cortical Degeneration with Swollen Chromatolytic Neurons: Its Relationship to Pick's Disease

J. Coyle, A. Clark, C. White, 1986, Journal of neuropathology and experimental neurology.

The hNT Human Neuronal Cell Line Survives and Migrates into Rat Retina

F. Sessler, J. Lehmann, L. Luo, 1998, Cell transplantation.

Cerebral uric acid increases following experimental traumatic brain injury in rat

J. W. Lighthall, J. Lehmann, C. Katsetos, 1996, Brain Research.

Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain

R. Lin, J. Lehmann, A. Jeng, 1999, Neuroscience.

NMDA- and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer yellow

R. Miller, N. Monsul, J. Lehmann, 1996, Journal of the Neurological Sciences.

Modified Chromenes as Precursors to TAAR Regulators

J. Lehmann, 2011 .

The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils

J. Liebman, J. Lehmann, C. Boast, 1988, Brain Research.

CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.

J. Lehmann, D. A. Bennett, D. Murphy, 1987, The Journal of pharmacology and experimental therapeutics.

Phenoxybenzamine blocks dopamine autoreceptors irreversible: implications for multiple dopamine receptor hypotheses.

J. Lehmann, S. Z. Langer, 1981, European journal of pharmacology.

Pharmacological studies on nitro‐naproxen (naproxen‐2‐nitrooxyethylester)

C. S. Patil, S. Kulkarni, R. E. Kartasasmita, 2004 .

Cortical norepinephrine release elicited in situ by N-methyl-d-aspartate (NMDA) receptor stimulation: a microdialysis study

R. Valentino, J. Lehmann, V. Robine, 1992, Brain Research.

The selective protein kinase C inhibitor, NPC 15437, induces specific deficits in memory retention in mice.

C. Mathis, J. Lehmann, A. Ungerer, 1992, European Journal of Pharmacology.

Central phencyclidine (PCP) receptor binding is glutamate dependent: evidence for a PCP/excitatory amino acid receptor (EAAR) complex

M. Williams, J. Lehmann, P. Loo, 1986 .

Neuropeptide Y: An overview

J. Lehmann, 1990 .

Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.

M. Williams, J. Lehmann, P. Loo, 1987, Molecular pharmacology.

Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists.

M. Williams, J. Lehmann, P. Loo, 1986, European journal of pharmacology.

Trans-2-carboxy-3-pyrrolidineacetic acid (CPAA), a novel agonist at NMDA-type receptors

J. Lehmann, C. Tsai, J. Schneider, 1988, Neuroscience Letters.

Effects of putative cognition enhancers on the NMDA receptor by [3H]MK801 binding.

J. Lehmann, S. Hamelin, John C. Lehmann, 1995, European journal of pharmacology.

Presynaptic Nicotinic Cholinergic Receptors Labeled by [3H]Acetylcholine on Catecholamine and Serotonin Axons in Brain

R. D. Schwartz, K. Kellar, J. Lehmann, 1984, Journal of neurochemistry.

Presynaptic Receptors on Catecholamine Neurones

J. Lehmann, S. Z. Langer, 1988 .

Chapter 4 Excitatory Amino Acids and Mammalian CNS Function

M. Williams, J. Lehmann, J. Schneider, 1987 .

N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids

B. Scatton, J. Lehmann, 1982, Nature.

Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices

B. Scatton, J. Lehmann, 1982, Brain Research.

Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

M. Briley, J. Lehmann, S. Z. Langer, 1983, European journal of pharmacology.

Basal forebrain neurons provide major cholinergic innervation of primate neocortex

J. Coyle, M. Delong, D. Price, 1986, Neuroscience Letters.

Regional heterogeneity of choline acetyltransferase activity in primate neocortex

J. Coyle, D. Price, P. Antuono, 1984, Brain Research.

Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntington's disease

H. Fibiger, P. Sanberg, J. Lehmann, 1978, Brain Research.

The localization of GABA-transaminase in the striato-nigral system.

S. Vincent, E. Mcgeer, J. Lehmann, 1980, Life sciences.

The nucleus basalis magnocellularis: The origin of a cholinergic projection to the neocortex of the rat

H. Fibiger, S. Atmadja, J. Nagy, 1980, Neuroscience.

CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.

C. Sinton, M. Williams, J. Lehmann, 1988, The Journal of pharmacology and experimental therapeutics.

The imidazoline-preferring receptor.

J. Lehmann, P. Vitou, E. Koenig-Bérard, 1989, Life sciences.

Muscarinic receptors on dopamine terminals in the cat caudate nucleus: Neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine

J. Lehmann, S. Z. Langer, 1982, Brain Research.

Acetylcholinesterase and the cholinergic neuron.

H. Fibiger, J. Lehmann, John Lehmann, 1979, Life sciences.

Glycine-evoked release of [3H]acetylcholine from rat striatal slices is independent of the NMDA receptor

J. Lehmann, C. Tsai, Cynthia A. Taylor, 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

The Pharmacological Distinction between Central Pre- and Post-synaptic Dopamine Receptors: Implications for the Pathology and Therapy of Schizophrenia

J. Lehmann, S. Z. Langer, 1982 .

Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron.

J. Coyle, J. Lehmann, J. Ferkany, 1985, The Journal of pharmacology and experimental therapeutics.

7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions

P. Wood, J. Lehmann, Dominique Procureur, 1993, Brain Research.

Homocysteic Acid as a Putative Excitatory Amino Acid Neurotransmitter: I. Postsynaptic Characteristics at N‐Methyl‐D‐Aspartate‐Type Receptors on Striatal Cholinergic Interneurons

P. Wood, J. Lehmann, C. Tsai, 1988, Journal of neurochemistry.

Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (pcp) binding site: tentative evidence for pcp recognition sites not coupled to n-methyl-d-aspartate (nmda) receptors

H. Kim, P. Wood, T. Rao, 1990, Neuropharmacology.

S 14506: A novel, potent, high‐efficacy 5‐HT1A agonist and potential anxiolytic agent

M. Millan, F. Colpaert, J. Rivet, 1992 .

The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals?

J. Lehmann, S. Z. Langer, 1983, Neuroscience.

Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.

M. Williams, J. Lehmann, D. Murphy, 1987, The Journal of pharmacology and experimental therapeutics.

Interactions of Phencyclidine Receptor Agonist MK‐801 with Dopaminergic System: Regional Studies in the Rat

P. Wood, T. Rao, J. Lehmann, 1990, Journal of neurochemistry.

ACETYLCHOLINESTERASE IN THE SUBSTANTIA NIGRA AND CAUDATE‐PUTAMEN OF THE RAT: PROPERTIES AND LOCALIZATION IN DOPAMINERGIC NEURONS

H. Fibiger, J. Lehmann, 1978, Journal of neurochemistry.

Dopamine receptors modulating [3H]acetylcholine release in slices of the cat caudate: effects of (-)-N-(2-chloroethyl)-norapomorphine.

C. R. Lee, J. Lehmann, S. Z. Langer, 1983, European journal of pharmacology.

Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: effects of (-)-N-(2-chloroethyl)-norapomorphine.

J. Lehmann, S. Z. Langer, 1982, European journal of pharmacology.

Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists: evidence for possible allosteric coupling of NMDA and PCP receptors.

P. Wood, D. Cheney, J. Lehmann, 1987, Canadian journal of physiology and pharmacology.

The localization of acetylcholinesterase in the corpus striatum and substantia nigra of the rat following kainic acid lesion of the corpus striatum: A biochemical and histochemical study

L. Butcher, H. Fibiger, J. Lehmann, 1979, Neuroscience.

Tiletamine is a potent inhibitor of N-methyl-aspartate-induced depolarizations in rat hippocampus and striatum.

R. Fisher, R. Bohacek, J. Lehmann, 1987, The Journal of pharmacology and experimental therapeutics.

Stereoisomers of apomorphine differ in affinity and intrinsic activity at presynaptic dopamine receptors modulating [3H]dopamine and [3H]acetylcholine release in slices of cat caudate.

J. Lehmann, S. Z. Langer, R. Smith, 1983, European journal of pharmacology.

Paradoxical convulsant action of a novel non-competitiveN-methyl-d-aspartate (NMDA) antagonist, tiletamine

T. Klockgether, K. Sontag, J. Lehmann, 1988, Brain Research.

NMDA receptors: the first decade

J. Lehmann, J. Vender, S. Nair, 1994 .

Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo.

H. Kim, P. Wood, T. Rao, 1989, Life sciences.

Primary Degenerative Dementia Without Alzheimer Pathology

J. Coyle, P. Whitehouse, A. Clark, 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Anatomical Organization of Some Cholinergic Systems in the Mammalian Forebrain

H. Fibiger, J. Lehmann, 1981 .

CGS 19755 is a potent and competitive antagonist at NMDA-type receptors.

P. Wood, B. Meldrum, J. Lehmann, 1988, European journal of pharmacology.

Cortical Cholinergic Innervation: Distribution and Source in Monkeys

J. Coyle, D. Price, S. Mitchell, 1986 .

Evidence for a GABA-containing projection from the entopeduncular nucleus to the lateral habenula in the rat

H. Fibiger, J. Nagy, J. Lehmann, 1978, Brain Research.

Excitatory amino acid receptors: NMDA modulatory sites, kainate cloned and a new role in AIDS

I. Reynolds, J. Lehmann, J. Randle, 1990 .

5-HT,. Agonist and Potential Anxiolytic Agent

M. Millan, F. Colpaert, J. Rivet, 2004 .

Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: Slight effect of ascorbate

J. Lehmann, S. Z. Langer, S. Arbilla, 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties.

J. Liebman, P. Wood, J. Lehmann, 1990, Progress in clinical and biological research.

Regional Distribution to Recovery of 5‐HT Levels after Administration of “Atrophins” MDMA and D, L‐Fenfluramine Stereospecificity and Comparison with 5,7‐Dihydroxytryptamine

J. Lehmann, E. Desouza, R. Zaczek, 1992, Annals of the New York Academy of Sciences.